Runway Growth Finance Corp.
RWAYAnalytical Summary
Runway Growth Finance Corp. shows mixed fundamentals. Further due diligence is recommended before making investment decisions.
23-Year Financial Trajectory
QuarterlyHealth Breakdown
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Dec 31, 2021 10-K ↗ | Q3 FY2021 Sep 30, 2021 10-Q ↗ | Q2 FY2021 Jun 30, 2021 10-Q ↗ | Q1 FY2021 Dec 31, 2020 10-Q ↗ | Q4 FY2020 Dec 31, 2020 10-K ↗ | Q4 FY2019 Dec 31, 2019 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Growth YoY (%) | N/M |
-71.6%
Weak
↓
Weak
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
-66.2%
Weak
↓
Weak
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
114.3%
Excellent
↑
Excellent
Improving
Year-over-year change in earnings per share
Optimal:
> 10%
|
-83.3%
Weak
↓
Weak
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
N/M |
75.7%
Excellent
↑
Excellent
Improving
Year-over-year change in earnings per share
Optimal:
> 10%
|
-61.8%
Weak
↓
Weak
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
0.0%
Caution
Caution
Year-over-year change in earnings per share
Optimal:
> 10%
|
N/M |
27.6%
Excellent
↓
Excellent
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
N/M |
328.6%
Excellent
↑
Excellent
Improving
Year-over-year change in earnings per share
Optimal:
> 10%
|
-11.5%
Weak
Weak
Year-over-year change in earnings per share
Optimal:
> 10%
|
-6.5%
Weak
Weak
Year-over-year change in earnings per share
Optimal:
> 10%
|
— | — | — | — | — | — | — | — |
| Net Income Growth YoY (%) | N/M |
-73.9%
Weak
↓
Weak
Declining
Year-over-year change in net income |
-68.0%
Weak
↓
Weak
Declining
Year-over-year change in net income |
102.6%
Excellent
↑
Excellent
Improving
Year-over-year change in net income |
-84.5%
Weak
↓
Weak
Declining
Year-over-year change in net income |
N/M |
69.0%
Excellent
↑
Excellent
Improving
Year-over-year change in net income |
-62.9%
Weak
↓
Weak
Declining
Year-over-year change in net income |
0.5%
Caution
Caution
Year-over-year change in net income |
N/M |
26.4%
Excellent
↓
Excellent
Declining
Year-over-year change in net income |
N/M |
320.0%
Excellent
↑
Excellent
Improving
Year-over-year change in net income |
-4.2%
Weak
Weak
Year-over-year change in net income |
14.6%
Fair
Fair
Year-over-year change in net income |
— | — | — | — | — | — | — | — |
| FCF Growth YoY (%) |
-91.7%
Weak
Weak
Year-over-year change in free cash flow |
— | — | — |
16.0%
Good
Good
Year-over-year change in free cash flow |
— | — | — | N/M | — | — | — |
2.0%
Caution
Caution
Year-over-year change in free cash flow |
— | — | — | — | — | — | — | — | — | — |
| EPS CAGR 3Y (%) | — |
-23.0%
Weak
↓
Weak
Declining
Compound annual EPS growth over 3 years |
-8.8%
Weak
↓
Weak
Declining
Compound annual EPS growth over 3 years |
— |
-10.6%
Weak
↓
Weak
Declining
Compound annual EPS growth over 3 years |
12.5%
Good
Good
Compound annual EPS growth over 3 years |
28.0%
Excellent
Excellent
Compound annual EPS growth over 3 years |
— | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Dec 31, 2021 10-K ↗ | Q3 FY2021 Sep 30, 2021 10-Q ↗ | Q2 FY2021 Jun 30, 2021 10-Q ↗ | Q1 FY2021 Dec 31, 2020 10-Q ↗ | Q4 FY2020 Dec 31, 2020 10-K ↗ | Q4 FY2019 Dec 31, 2019 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FCF / Net Income (x) |
-0.17x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
2.80x
Excellent
↓
Excellent
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
11.52x
Excellent
↓
Excellent
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.02x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
39.42x
Excellent
Excellent
Free cash flow relative to reported net income
Optimal:
> 1x
|
0.49x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — |
5.69x
Excellent
Excellent
Free cash flow relative to reported net income
Optimal:
> 1x
|
12.88x
Excellent
Excellent
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — |
-1.55x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
-10.58x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
— |
65.74x
Excellent
↑
Excellent
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-6.77x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
-3.43x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — | — | — | — |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Dec 31, 2021 10-K ↗ | Q3 FY2021 Sep 30, 2021 10-Q ↗ | Q2 FY2021 Jun 30, 2021 10-Q ↗ | Q1 FY2021 Dec 31, 2020 10-Q ↗ | Q4 FY2020 Dec 31, 2020 10-K ↗ | Q4 FY2019 Dec 31, 2019 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Common Equity (%) (%) |
-7.9%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
1.5%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
1.6%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
3.4%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
0.4%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
5.5%
Caution
↑
Caution
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
4.9%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
1.6%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
2.3%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
-0.9%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
2.6%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
3.9%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
2.1%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
3.2%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
2.0%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
-0.1%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
0.5%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
3.2%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
2.0%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
— | — | — | — |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Dec 31, 2021 10-K ↗ | Q3 FY2021 Sep 30, 2021 10-Q ↗ | Q2 FY2021 Jun 30, 2021 10-Q ↗ | Q1 FY2021 Dec 31, 2020 10-Q ↗ | Q4 FY2020 Dec 31, 2020 10-K ↗ | Q4 FY2019 Dec 31, 2019 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt to Equity (x) |
0.97x
Fair
→
Fair
Stable
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
0.90x
Fair
↓
Fair
Declining
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
0.91x
Fair
↓
Fair
Declining
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
1.03x
Caution
→
Caution
Stable
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
0.98x
Fair
↓
Fair
Declining
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
1.07x
Caution
↑
Caution
Improving
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
1.07x
Caution
↑
Caution
Improving
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
1.08x
Caution
↑
Caution
Improving
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
0.90x
Fair
→
Fair
Stable
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
— |
0.77x
Fair
↓
Fair
Declining
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
0.95x
Fair
↑
Fair
Improving
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
1.02x
Caution
Caution
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
— |
0.59x
Good
Good
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
— | — | — | — | — | — | — | — |
| Net Debt (USD) | $424.63M | $417.16M | $435.59M | $509.99M | $473.85M | $546.58M | $538.89M | $539.88M | $469.00M | — | $426.04M | $509.53M | $580.65M | — | $330.77M | — | — | — | — | — | — | — | — |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Dec 31, 2021 10-K ↗ | Q3 FY2021 Sep 30, 2021 10-Q ↗ | Q2 FY2021 Jun 30, 2021 10-Q ↗ | Q1 FY2021 Dec 31, 2020 10-Q ↗ | Q4 FY2020 Dec 31, 2020 10-K ↗ | Q4 FY2019 Dec 31, 2019 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LT Debt (USD) | $426.94M | $435.34M | $443.51M | $515.95M | $492.21M | $552.33M | $542.51M | $548.69M | $475.91M | — | $440.99M | $547.27M | $583.92M | — | $336.54M | — | — | — | — | — | — | — | — |
| Total Equity (USD) | $438.23M | $484.97M | $489.53M | $498.87M | $503.29M | $514.87M | $507.36M | $506.38M | $529.47M | $547.07M | $570.49M | $573.90M | $569.81M | $576.05M | $573.66M | $579.41M | $597.47M | $606.20M | $504.20M | $477.74M | $466.24M | $466.24M | $376.31M |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Dec 31, 2021 10-K ↗ | Q3 FY2021 Sep 30, 2021 10-Q ↗ | Q2 FY2021 Jun 30, 2021 10-Q ↗ | Q1 FY2021 Dec 31, 2020 10-Q ↗ | Q4 FY2020 Dec 31, 2020 10-K ↗ | Q4 FY2019 Dec 31, 2019 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income, GAAP (USD) | $-34.82M | $7.37M | $8.02M | $16.80M | $1.87M | $28.22M | $25.05M | $8.29M | $12.05M | $-4.79M | $14.82M | $22.32M | $11.98M | $18.49M | $11.72M | $-817.00K | $2.85M | $19.31M | $10.23M | — | — | — | — |
| Operating Cash Flow (USD) | $5.93M | $20.63M | $92.42M | $-297.00K | $73.56M | $13.89M | — | — | $68.60M | $-61.64M | — | — | $-18.53M | $-195.73M | — | $-53.71M | $-19.31M | $-66.20M | — | — | — | — | — |
Secondary lens
Benchmark Lens
Compare RWAY against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare RWAY against peers after checking the statement evidence.
Percentile Rankings
How RWAY compares to all companies
Compare RWAY with peers
Stack RWAY against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 10 years · 23 quarters